Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ADCY3 |
| Upstream (Parents) |
|---|
| (<<) CXCL2 → ADCY3 |
| (<<) EPHB2 → ADCY3 |
| (<<) NEDD4 → ADCY3 |
| (<<) PLCG1 → ADCY3 |
| (<<) RASA1 → ADCY3 |
| (<<) RNF11 → ADCY3 |
| (<<) RPIA → ADCY3 |
| (<<) SHC2 → ADCY3 |
| (<<) SOD1 → ADCY3 |
| (<<) ST3GAL6 → ADCY3 |
| Downstream (Children) |
|---|
| ADCY3 → CLCA4 (>>) |
| ADCY3 → FZD6 (>>) |
| ADCY3 → INPP5D (>>) |
| ADCY3 → NFAT5 (>>) |
| ADCY3 → PRDX6 (>>) |
| ADCY3 → PROCR (>>) |
| ADCY3 → PYGB (>>) |
| ADCY3 → RPS28 (>>) |
| ADCY3 → SHC1 (>>) |
| ADCY3 → SPR (>>) |
| ADCY3 → STAT6 (>>) |
